Platinum Investment Management LTD Ovid Therapeutics Inc. Transaction History

Platinum Investment Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.65 - $3.49 $2.03 Million - $2.68 Million	-766,901 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$3.31 - $4.04 $1.22 Million - $1.49 Million	370,031 Added 93.24%	766,901 $2.58 Million
Q4 2020 Feb 12, 2021	BUY	$2.28 - $6.84 $372,681 - $1.12 Million	163,457 Added 70.03%	396,870 $917,000
Q3 2020 Nov 13, 2020	SELL	$5.39 - $8.24 $367,468 - $561,770	-68,176 Reduced 22.61%	233,413 $1.34 Million
Q2 2020 Aug 06, 2020	SELL	$2.67 - $7.91 $217,193 - $643,446	-81,346 Reduced 21.24%	301,589 $2.22 Million
Q1 2020 May 15, 2020	BUY	$2.03 - $4.35 $155,881 - $334,032	76,789 Added 25.08%	382,935 $1.14 Million
Q4 2019 Feb 13, 2020	BUY	$2.08 - $5.06 $367,215 - $893,322	176,546 Added 136.22%	306,146 $1.27 Million
Q3 2019 Nov 14, 2019	BUY	$1.76 - $3.51 $228,096 - $454,896	129,600 New	129,600 $420,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $68.3M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.